• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Merck Ophthalmics

What!?!? College grad? Contract sales force...oh great just what Ophthalmology needs. Pretty soon it will be.must like PC and docs won't see reps anymore. What a joke. Open it up, I know there are people who were in the old Ophthalmology group who would come back in a heartbeat if given the opp.

What's this I hear that Merck is going to try this experiment one more time? Are they crazy? 3times and your out!